← All indications
Respiratory Distress Syndrome, Newborn
A condition of the newborn marked by DYSPNEA with CYANOSIS, heralded by such prodromal signs as dilatation of the alae nasi, expiratory grunt, and retraction of the suprasternal notch or costal margins, mostly frequently occurring in premature infants, children of diabetic mothers, and infants delivered by cesarean section, and sometimes with no apparent predisposing cause.
Subtype terms (2)
More specific conditions that are subtypes of Respiratory Distress Syndrome, Newborn in the MeSH hierarchy.
- Hyaline Membrane Disease
7 drugs (6 approved, 1 experimental)
- Transient Tachypnea of the Newborn
8 drugs approved
Drugs by status
Approved for this indication (7)
Phase 4 trials (4)
Phase 3 trials (2)
Phase 1 trials (3)
Organizations
Organization Involved with Phase 4 Indications (45)
- Merck
- United States Army
- Cairo University
- Istanbul University
- University of Arizona
- Poznan University
- University of London
- National Taiwan University
- Ege University
- Mario Negri Institute
- Taipei Medical University
- Consorcio Centro de Investigación Biomédica en Red, M.P.
- Federal University of Minas Gerais
- Marche Polytechnic University
- Maternite Regionale Universitaire
- Radboud University
- Taipei Veteran General hospital
- Aix-University of Marseille
- Li Ka Shing Knowledge Institute
- Albany Medical College
- Chung Shan Medical University
- Pontificia Universidad Catolica de Chile
- Mackay Medical College
- Universidad Autonoma de San Luis Potosi
- University of Lorraine
- Huazhong University of Science and Technology
- Southeast University
- Chiesi
- Cathay General Hospital
- Assiut University
- +15 more
Organization Involved with Phase 3 Indications (155)
- National Center for Research Resources (NCRR)
- Emory University
- Federal University of Juiz de Fora
- Lady Hardinge Medical College
- Baylor University
- Alexion
- Centre Hospitalier de Douai
- University of California, Berkeley
- University of Alabama, Birmingham
- University of Grenoble
- University of Franche-Comté
- University of Picardie Jules Verne
- CHU La Timone
- Indiana University
- University of Athens
- University of Alberta
- Mallinckrodt
- University of Virginia
- Mayo Clinic
- University of Nantes
- University of Montpellier
- University of Sydney
- Pneuma Pharmaceuticals Incorporated
- University of Ottawa
- University of Wisconsin
- University of Padua
- University of Massachusetts
- Albert Einstein Israelite Hospital
- Brown University
- University of Toronto
- +125 more
Organization Involved with Phase 2 Indications (130)
- Target Health Inc.
- Organicell Regenerative Medicine, Inc
- American Society for Parenteral and Enteral Nutrition
- Government of Egypt
- Clinica Universidad de Navarra
- Guangzhou Medical University
- Veru Inc.
- Kyoto Prefectural University of Medicine
- SP ZOZ Szpital Uniwersytecki w Krakowie Oddizat Neonatologii
- AVM Biotechnology LLC
- Cartesian Therapeutics
- GlaxoSmithKline
- University of Colorado
- National Cancer Center, Korea
- Indiana Clinic
- Lavin Consulting, LLC
- University of Iowa
- Harborview Injury Prevention and Research Center
- University of Winnipeg
- Institut de Cancerologie Strasbourg Europe
- Instytut Centrum Zdrowia Matki Polki Klinika Neonatologii
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- King Abdul-Aziz University
- Eli Lilly
- Rio de Janeiro Federal University
- University of Salamanca
- Cardiff University
- Ohio State University
- Acticor Biotech
- Yeshiva University
- +100 more
Organization Involved with Phase 1 Indications (24)
- National Institute of Allergy and Infectious Diseases (NIAID)
- Pennsylvania State University
- University of Oklahoma
- Medical Center of Central Georgia
- MiNK Therapeutics
- Pomeranian Medical University
- National Cancer Institute (NCI)
- Celerion
- Stem Cell Network
- Shaoxing Second Hospital
- Ain Shams University
- Government of Italy
- Medical University of Warsaw
- Tanox
- Savara Inc.
- Sun Yat-Sen University
- University of South Carolina
- Methodist Cancer Center, Houston, Texas
- Uppsala University
- State University of New York
- Jazz Pharmaceuticals
- Instituto de Medicina Regenerativa
- Agenus Inc.
- Meridigen Biotech Co., Ltd.
Organization Involved with Other Experimental Indications (50)
- Institute for the Care of Mother and Child, Prague, Czech Republic
- Philipps University of Marburg
- University of Kansas
- King Edward Medical University
- Winthrop University
- University of Cologne
- Lund University
- Humboldt University
- Qingdao University
- University of Antwerp
- University of Hamburg
- Washington University in St. Louis
- Azienda Ospedaliera San Gerardo di Monza
- Vestische Kinder- und Jugendklinik Datteln
- University of Florence
- German Federal Ministry of Education and Research
- Hospital of Leverkusen
- Emek Medical Center
- Central Hospital, Zibo
- Technion University
- Northern State Medical University
- University of Amsterdam
- Monash University
- Dr. Sami Ulus Children's Hospital
- Klinikum Aschaffenburg-Alzenau
- Zhengzhou University
- Government of Pakistan
- Kilimanjaro Christian Medical College, Tanzania
- Sami Ulus Maternity and Childrens Hospital
- Henan Medical University
- +20 more